Titre : bêta-Alanine

bêta-Alanine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reference Values
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "bêta-Alanine : Questions médicales les plus fréquentes", "headline": "bêta-Alanine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les bêta-Alanine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "bêta-Alanine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Alanine", "url": "https://questionsmedicales.fr/mesh/D000409", "about": { "@type": "MedicalCondition", "name": "Alanine", "code": { "@type": "MedicalCode", "code": "D000409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.042" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acide pantothénique", "alternateName": "Pantothenic Acid", "url": "https://questionsmedicales.fr/mesh/D010205", "about": { "@type": "MedicalCondition", "name": "Acide pantothénique", "code": { "@type": "MedicalCode", "code": "D010205", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.042.070.500" } } } ], "about": { "@type": "MedicalCondition", "name": "bêta-Alanine", "alternateName": "beta-Alanine", "code": { "@type": "MedicalCode", "code": "D015091", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bryan Saunders", "url": "https://questionsmedicales.fr/author/Bryan%20Saunders", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, Rheumatology Division, Faculdade de Medicina FMUSP, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Eimear Dolan", "url": "https://questionsmedicales.fr/author/Eimear%20Dolan", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, Rheumatology Division, Faculdade de Medicina FMUSP, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Bruno Gualano", "url": "https://questionsmedicales.fr/author/Bruno%20Gualano", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, School of Physical Education and Sport; Rheumatology Division; Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, SP, BR, University of São Paulo, Brazil." } }, { "@type": "Person", "name": "Marcelo Papoti", "url": "https://questionsmedicales.fr/author/Marcelo%20Papoti", "affiliation": { "@type": "Organization", "name": "University of São Paulo, Medicine University of Ribeirão Preto (FMRP-USP), Ribeirão Preto, São Paulo, Brazil." } }, { "@type": "Person", "name": "Craig Sale", "url": "https://questionsmedicales.fr/author/Craig%20Sale", "affiliation": { "@type": "Organization", "name": "Musculoskeletal Physiology Research Group, Sport, Health and Performance Enhancement Research Centre, Nottingham Trent University, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Value of Including the Children's Experience for Improving Their Rights During Hospitalization: Protocol for the VoiCEs Project.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37010905", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/42804" } }, { "@type": "ScholarlyArticle", "name": "Nutritive value of active volatile components of Anacardiaceae mango and their effects on carrier proteins function.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37120228", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.foodres.2023.112779" } }, { "@type": "ScholarlyArticle", "name": "Prognostic value of systemic immune-inflammation index/ albumin for transcatheter arterial chemoembolization treatment.", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37151715", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2023.e15156" } }, { "@type": "ScholarlyArticle", "name": "Clinical application of Vitek-derived minimum inhibitory concentration values: Proof of concept study.", "datePublished": "2023-03-31", "url": "https://questionsmedicales.fr/article/37063451", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/sajid.v38i1.498" } }, { "@type": "ScholarlyArticle", "name": "Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.", "datePublished": "2023-03-31", "url": "https://questionsmedicales.fr/article/37004015", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-023-10751-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Acides aminés", "item": "https://questionsmedicales.fr/mesh/D000596" }, { "@type": "ListItem", "position": 4, "name": "Alanine", "item": "https://questionsmedicales.fr/mesh/D000409" }, { "@type": "ListItem", "position": 5, "name": "bêta-Alanine", "item": "https://questionsmedicales.fr/mesh/D015091" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : bêta-Alanine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur bêta-Alanine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur bêta-Alanine", "description": "Comment diagnostiquer une carence en bêta-alanine ?\nQuels tests peuvent évaluer les niveaux de bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Reference+Values&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur bêta-Alanine", "description": "Quels sont les symptômes d'une supplémentation excessive en bêta-alanine ?\nLa bêta-alanine cause-t-elle des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Reference+Values&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur bêta-Alanine", "description": "Comment prévenir une carence en bêta-alanine ?\nLes sportifs doivent-ils se supplémenter en bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Reference+Values&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur bêta-Alanine", "description": "La bêta-alanine est-elle utilisée pour traiter des maladies ?\nComment la bêta-alanine améliore-t-elle la performance ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Reference+Values&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur bêta-Alanine", "description": "Quelles complications peuvent survenir avec une surconsommation ?\nLa bêta-alanine peut-elle interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Reference+Values&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur bêta-Alanine", "description": "Qui est à risque de carence en bêta-alanine ?\nLes athlètes d'endurance ont-ils besoin de plus de bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Reference+Values&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en bêta-alanine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de test spécifique; une évaluation des symptômes et des apports alimentaires est nécessaire." } }, { "@type": "Question", "name": "Quels tests peuvent évaluer les niveaux de bêta-alanine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines peuvent mesurer les niveaux d'acides aminés, y compris la bêta-alanine." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une supplémentation excessive en bêta-alanine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une supplémentation excessive peut provoquer des picotements, des démangeaisons ou des rougeurs." } }, { "@type": "Question", "name": "La bêta-alanine cause-t-elle des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des picotements peuvent survenir, mais ils sont généralement bénins." } }, { "@type": "Question", "name": "Comment prévenir une carence en bêta-alanine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée incluant des sources de protéines peut prévenir une carence." } }, { "@type": "Question", "name": "Les sportifs doivent-ils se supplémenter en bêta-alanine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les sportifs peuvent bénéficier d'une supplémentation pour améliorer leur endurance et performance." } }, { "@type": "Question", "name": "La bêta-alanine est-elle utilisée pour traiter des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle n'est pas un traitement médical, mais un complément pour améliorer la performance sportive." } }, { "@type": "Question", "name": "Comment la bêta-alanine améliore-t-elle la performance ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle augmente les niveaux de carnosine dans les muscles, retardant la fatigue lors d'exercices intenses." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une surconsommation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles gastro-intestinaux et des picotements." } }, { "@type": "Question", "name": "La bêta-alanine peut-elle interagir avec d'autres médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions sont possibles; il est conseillé de consulter un professionnel de santé." } }, { "@type": "Question", "name": "Qui est à risque de carence en bêta-alanine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant une alimentation pauvre en protéines ou végétalienne peuvent être à risque." } }, { "@type": "Question", "name": "Les athlètes d'endurance ont-ils besoin de plus de bêta-alanine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir besoin de plus de bêta-alanine pour améliorer leur performance et récupération." } } ] } ] }

Sources (10000 au total)

Value of Including the Children's Experience for Improving Their Rights During Hospitalization: Protocol for the VoiCEs Project.

Users' feedback is a key asset for organizations that want to improve their services. Studying how organizations are enabling their users to participate in evaluation activities is particularly import... This paper describes the research protocol of a European project intended to develop and implement a systematic pediatric patient-reported experience measures (PREMs) observatory that will be shared b... The VoiCEs (Value of including the Children's Experience for improving their rightS during hospitalization) project uses a participatory action research approach, based on a mixture of qualitative and... The expected results are (1) a deeper knowledge of published methodologies and tools on collecting and reporting pediatric patients' voice; (2) lessons learnt from the analysis of previous experiences... Over the last decade, the collection and use of PREMs have gained importance as a research field. Children and adolescents' perspectives have also been increasingly taken into consideration. However, ... DERR1-10.2196/42804....

Prognostic value of systemic immune-inflammation index/ albumin for transcatheter arterial chemoembolization treatment.

In the process of tumor occurrence, evolution and development, immune, inflammation and nutrition are principal elements. The purpose of this study was to assess the prognostic value of systemic immun... A total of 125 HBV-related HCC patients met inclusion criteria and were all enrolled in this research. The survminer R package. was used to calculate the best SII/ALB cutoff values. Chi-square test wa... The cutoff value of SII/ALB was 2.992. In the derivation cohort, the patients were divided into SII/ALB-low (SII/ALB≤2.992) and SII/ALB-high (SII/ALB >2.992) groups. SII/ALB-high was found in patients...

Clinical application of Vitek-derived minimum inhibitory concentration values: Proof of concept study.

Minimum inhibitory concentration (MIC) values are useful in guiding appropriate antimicrobial therapy however, routine provision and interpretation of MIC values to guide clinical decision-making is c... This proof of concept study aims to demonstrate the clinical utility and application of Vitek... A random selection of clinically relevant Gram negative isolates routinely tested on the Vitek... A total of 525 isolates were included (468 Enterobacterales and 57... Vitek... Minimum inhibitory concentration data from an automated antimicrobial susceptibility testing instrument can be used to guide clinical decisions....

Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.

Disco-interaction protein 2 homologue B (DIP2B) plays an important role in DNA methylation. There have been many reports on DIP2B in various diseases, but neither the diagnostic value nor the prognost... The expression levels of DIP2B in 33 cancer types were analysed based on data sets from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) database. The relationships of DIP2B ex... DIP2B was highly expressed in 26 of 33 cancer types and was significantly associated with poor overall survival (OS) in breast invasive carcinoma (BRCA), mesothelioma and chromophobe renal cell carcin... DIP2B may be a prognostic biomarker for BRCA, especially for the Her-2 + subtype. DIP2B is associated with a "cold" tumour immune microenvironment in BRCA and might serve as a future target for immuno...

Preoperative history and physical update visits offer limited clinical value in colorectal surgery.

United States regulations require a history and physical (H&P) ≤30 days before planned procedures. We evaluated the impact of H&P update visits in colorectal surgery.... Preoperative H&P update visits conducted in colorectal clinics at our institution during 2019 were identified. Two independent reviewers assessed whether update visits identified interval changes to h... For 132 visits, interval changes were identified in 39% of histories, but only 4.2% of exams and 6.8% of operative plans. When plans changed, visit goals could have been accomplished via telehealth in... H&P update visits conducted to satisfy the 30-day regulation rarely result in clinically relevant changes yet impose time and travel burdens on patients. Regulations should be revised to provide flexi...

Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients With Precapillary Pulmonary Hypertension.

Precapillary pulmonary hypertension is characterized by elevated mean pulmonary artery pressure from increased pulmonary vascular resistance. Lack of respiratory variation in right atrial pressure can... Is the lack of respiratory variation in right atrial pressure predictive of right ventricular dysfunction and worse clinical outcomes in precapillary pulmonary hypertension?... We retrospectively reviewed right atrial pressure tracings of patients with precapillary pulmonary hypertension who underwent right heart catheterization. Patients with respiratory variation in right ... Lack of respiratory variation in right atrial pressure was associated with lower cardiac index by indirect Fick (2.34 ± 0.09 vs 2.76 ± 0.1 L/min/m... Lack of respiratory variation in right atrial pressure is associated with poor clinical outcomes, adverse hemodynamic parameters, and right ventricular dysfunction in patients with precapillary pulmon...

Predictive Value of Blood Markers in Nonfunctional Pituitary Adenomas using Artificial Neural Network.

Nonfunctioning pituitary adenomas (NFPAs) are the most common pituitary tumors and although they do not secrete hormones, they can have systemic effects. These tumors affect the function of other orga... This article compared the blood markers of NFPAs with healthy individuals retrospectively. The difference between blood markers in the two groups was statistically investigated where the predictive va... A total of 96 NFPAs (nonfunctional pituitary adenoma) and 96 healthy individuals were evaluated. There was statistically a significant difference and positive correlation in platelet to lymphocyte rat... There are differences between blood markers in NFPAs relative to healthy people and the artificial neural network can accurately differentiate between them....

General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations.

Expected value of sample information (EVSI) quantifies the expected value to a decision maker of reducing uncertainty by collecting additional data. EVSI calculations require simulating plausible data... We developed a discrete sampling method and an interpolated ITS method for simulating survival data from a probabilistic sample of survival probabilities over discrete time units. We compared the gene... The discrete sampling and interpolated ITS methods agree closely with the standard ITS method, with the added benefit of a greatly reduced computational cost in the scenario with adjustment for treatm... We present general-purpose methods for simulating survival data from a probabilistic sample of survival probabilities that greatly reduce the computational burden of the EVSI data-simulation step when... Expected value of sample information (EVSI) quantifies the expected value to a decision maker of reducing uncertainty through a given data collection exercise, such as a randomized clinical trial. In ...